Peter Reichardt
Peter Reichardt publishes mostly in Pulmonary and Respiratory Medicine, Gastroenterology and Oncology, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Gastric Cancer Management and Outcomes.
- World rank
- #86,577 of 7,710,434 ranked researchers
- Rank in Germany
- #4,693 of 364,343
- Works
- 646
- Citations
- 36k
- Citations per work
- 55.3
What does Peter Reichardt research?
Peter Reichardt's work is mostly in Medicine (67%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences43667.5%
- Medicine43667.5%
- Everything else18528.6%
- Life Sciences253.9%
- 1Pulmonary and Respiratory Medicine25% of their works
- 2Gastroenterology15% of their works
- 3Oncology12% of their works
- 4Surgery10% of their works
- 5Rheumatology5% of their works
- 6Immunology4% of their works
Research topics
- Sarcoma Diagnosis and Treatment
- Gastrointestinal Tumor Research and Treatment
- Gastric Cancer Management and Outcomes
- Gastrointestinal disorders and treatments
- Bone Tumor Diagnosis and Treatments
- Vascular Tumors and Angiosarcomas
- Colorectal Cancer Treatments and Studies
- Metastasis and carcinoma case studies
Which keywords describe Peter Reichardt's research?
The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Clinical Practice Guidelines, Osteosarcoma, Soft Tissue Sarcoma, Imatinib Mesylate, Sunitinib and Endoscopic Resection.
- Lung Tumors
- Cetuximab
- Angiosarcoma
- Chondrosarcoma
- Intussusception
- Endoscopic Resection
- Imatinib Mesylate
- Osteosarcoma
- Chemotherapy
- Prognostic Factors
- Clinical Practice Guidelines
- Soft Tissue Sarcoma
- Sunitinib
- Gastric Cancer
- Meckel's Diverticulum
- Chordoma
- Epithelioid Hemangioendothelioma
- KRAS Mutations
- Metastatic Carcinomas
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Prognostic Factors4072 topics
- Chemotherapy3573 topics
- Clinical Practice Guidelines3232 topics
- Osteosarcoma2081 topic
- Soft Tissue Sarcoma2081 topic
- Imatinib Mesylate1991 topic
- Sunitinib1991 topic
- Endoscopic Resection1151 topic
- Gastric Cancer1151 topic
- Intussusception631 topic
- Meckel's Diverticulum631 topic
- Chondrosarcoma471 topic
- Chordoma471 topic
- Angiosarcoma461 topic
- Epithelioid Hemangioendothelioma461 topic
- Cetuximab341 topic
- KRAS Mutations341 topic
- Lung Tumors311 topic
- Metastatic Carcinomas311 topic
Where does Peter Reichardt work?
Peter Reichardt's main affiliation in the publication record is Helios Hospital Berlin-Buch, Germany.
How many publications and citations does Peter Reichardt have?
OpenAlex counts 646 works and 35,710 citations for Peter Reichardt, an h-index of 85, ranking #86,577 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter Reichardt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.